Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 150-155

  Tochikubo, Kunio ^a   Isaka, Masanori ^a   Yasuda, Yoko ^a   Kozuka, Satoshi ^a   Matano, Keiko ^a   Miura, Yutaka ^a   Taniguchi, Tooru ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Bovine serum albumin; Mucosal adjuvant; Recombinant cholera toxin B subunit

Indexed keywords

BOVINE SERUM ALBUMIN; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BREVIBACILLUS BREVIS; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; CHOLERA TOXIN; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; NASAL MUCOSA; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE;

EID: 0031986238     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00194-1     Document Type: Article

References (29)

1. 1 Elson, C.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984, 133, 2892-2897.
2. 2 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308.
3. 3 Nedrud, J.G., Liang, X., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 1987, 139, 3484-3492.
4. 4 Liang, X., Lamm, M.E. and Nedrud, J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 1988, 141, 1495-1501.
5. 5 Wilson, A.D., Clarke, C.J. and Stokes, C.R. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Imunol. 1990, 31, 443-451.
6. 6 Vajdy, M. and Lycke, N.Y. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after orat immunization. Immunology 1992, 75, 488-492.
7. 7 Tamura, S., Samegai, Y. and Kurata, H. et al. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409-413.
8. 8 Lee, A. and Chen, M. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infect. Immun. 1994, 62, 3594-3597.
9. 9 Vadolas, J., Davies, J.K., Wright, P.J. and Strugnell, R.A. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 1995, 25, 969-975.
10. 10 Hathaway, L.J., Partidos, C.D., Vohra, P. and Steward, M.W. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally. Vaccine 1995, 13, 1495-1500.
11. 11 Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. and Holmgren, J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 1989, 57, 1072-1077.
12. 12 Tamura, S., Yamanaka, A. and Shimohara, M. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426.
13. 13 McKenzie, S.J. and Halsey, J.F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 1984, 133, 1818-1824.
14. 14 Van der Heijden, P.J., Bianchi, A.T. and Dol, M. et al. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice. Immunology 1991, 72, 89-93.
15. 15 Dertzbaugh, M.T. and Elson, C.O. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 1993, 61, 48-55.
16. 16 Zhang, T., Li, E. and Stanley, S.L. Jr. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect Immun. 1995, 63, 1349-1355.
17. 17 Bergquist, C., Lagergård, T., Lindblad, M. and Holmgren, J. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 1995, 63, 2021-2025.
18. 18 Ichikawa, Y., Yamagata, H., Tochikubo, K. and Udaka, S. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiol. Lett. 1993, 111, 219-224.
19. 19 Haneberg, B, Kendall, D. and Amerongen, H.M. et al. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62, 15-23.
20. 20 Lycke, N., Tsuji, T. and Holmgren, J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 1992, 22, 2277-2281.
21. 21 Dickinson, B.L. and Clements, J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 1995, 63, 1617-1623.
22. 22 Spangler, B.D. Structure and function of cholera toxin and related Escherichia coli heat-labile enterotoxins. Microbiol. Rev. 1992, 56,622-647.
23. 23 Mosmann, T.R, and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7, 145-173.
24. 24 Street, N.E. and Mosmann, T.R, Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991, 5, 171-177.
25. 25 Takahashi, I., Marinaro, M. and Kiyono, H. et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 1996, 173, 627-635.
26. 26 Hörnquist, E. and Lycke, N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 1993, 23, 2136-2143.
27. 27 Oien, N.L., Brideau, R.J., Walsh, E.E. and Wathen, M.W. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 1994, 12, 731-735.
28. 28 Ogra, P.L. and Karzon, D.T. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J. Immunol. 1969, 102, 1423-1430.
29. 29 Elson, C.O., Ealding, W. and Lefkowitz, J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Meth. 1984, 67, 101-108.